UNC lab partnership develops first COVID-19 treatment approved by FDA
Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University.
(Daily Tar Heel)
Related: Campus Connections
Carolina celebrates the Class of 2024 at winter commencementAfter years of hard work — whether it be class readings, group projects, student group activities, papers, late nights studying or exams — graduating UNC...
Sun Dec 22, 2024A playlist of Chapel Hill-themed holiday songs
Joni Mitchell went Christmas caroling in the Morgan Creek neighborhood in December 1970 with her then boyfriend, James Taylor. Six months later, Mitchell’s album Blue...
Fri Dec 20, 2024
Video: New UNC Football coach Bill Belichick brings in big business for stores in Chapel Hill
Many Franklin Street businesses in Chapel Hill are reaping the benefits, following the news that Bill Belichick, one of the greatest NFL coaches of all...
Tue Dec 17, 2024
Carolina Insider Podcast: UNC vs. Florida Basketball preview, Hubert Davis joins, Be Loud! Sophie
UNC Basketball cruised past La Salle, but faces a much stiffer test Tuesday against Florida (2:20). Hubert Davis checks in (28:07). Niklaus and Lucy Steiner...
Tue Dec 17, 2024
